ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody takes aim at Hard-to-Treat cancers
Disease control OngoingThis Phase 2 trial is testing a drug called PRL3-zumab in 60 people with advanced solid tumors that have not responded to standard treatments. PRL3-zumab is an antibody designed to attach to a protein called PRL3 found on cancer cells, potentially helping the immune system attack…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer-Killing virus trial launches for Hard-to-Treat tumors
Disease control OngoingThis early-stage trial tests a modified virus called hV01 in 24 adults with advanced solid tumors that have not responded to standard treatments. The virus is injected directly into tumors and is designed to kill cancer cells while also boosting the immune system. The main goals …
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New cancer drug BNT314 enters first human safety trial
Disease control OngoingThis study is the first time BNT314 is being tested in humans. It aims to see if the drug is safe for people with advanced solid tumors that have not responded to other treatments. About 41 participants will receive different doses to find the highest dose that is still safe and …
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC